We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Islet Cell Antibodies

General information

Predictive of future insulin requirement in patients presenting with NIDDM (Non-insulin dependent diabetes mellitus) and in relatives of IDDM (Insulin dependent diabetes mellitus) patients.

Specimen transport: At room temperature

Repeat frequency: At significant change of clinical symptoms

Special precautions: None

Laboratory information

Normal reference range: Neg

Volume and sample type: 7ml clotted blood

Method: Immunofluorescence

Turnaround time (calendar days from sample receipt to authorised result): Median - 6

Clinical information

Indications for the test: Screening of first degree relatives for risk of developing insulin dependent diabetes mellitus. May also be used to determine the risk of IDDM in gestational diabetes

Factors affecting the test: Detectable within first year after diagnosis in IDDM patients. Antibody levels decline as islet cells are destroyed by the autoimmune disease process


ICE reference: Islet Cell Antibodies


(Last updated August 28th 2018)